Revenue
attach_money377M USD
YoY +26.9%
PHARPharming Group N.V.$ --
Pharming Group N.V.
PHAR
$ -
-
You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.
analyticsIncome Statement Summary
FY2025 Full YearUpdated: 12/31/2025
Operating Income
bar_chart19M USD
YoY +324.7%
Net Income
verified3M USD
YoY +124.1%
EPS
pie_chart0.04USD
YoY +123.5%
Quarterly Performance
Quarterly revenue and net income trend
RevenueOperating IncomeNet Income
No quarterly data available
Full-Year Progress
Net Income Progress128.5%On Track
Revenue Progress376M
Revenue Forecast387.8M
Net Income Progress2.8M
Net Income Forecast2.2M
Income Statement Details
Item
Revenue
Cost of revenue
Gross profit
Research & development
Selling & marketing
Selling, general and administrative
Other operating expenses
Operating income
Interest expense
Income before tax
Income tax expense
Net income
Unlock Long-Term Income Statement Data
Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.